| Literature DB >> 32636542 |
Daniel Shyu1, James Dorroh1, Caleb Holtmeyer1, Detlef Ritter2, Anandhi Upendran3, Raghuraman Kannan4, Dima Dandachi5, Christian Rojas-Moreno5, Stevan P Whitt6, Hariharan Regunath6.
Abstract
Diagnostic tests for the coronavirus infection 2019 (COVID-19) are critical for prompt diagnosis, treatment and isolation to break the cycle of transmission. A positive real-time reverse-transcriptase polymerase chain reaction (RT-PCR), in conjunction with clinical and epidemiologic data, is the current standard for diagnosis, but several challenges still exist. Serological assays help to understand epidemiology better and to evaluate vaccine responses but they are unreliable for diagnosis in the acute phase of illness or assuming protective immunity. Serology is gaining attention, mainly because of convalescent plasma gaining importance as treatment for clinically worsening COVID-19 patients. We provide a narrative review of peer-reviewed research studies on RT-PCR, serology and antigen immune-assays for COVID-19, briefly describe their lab methods and discuss their limitations for clinical practice. Copyright 2020 by the Missouri State Medical Association.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32636542 PMCID: PMC7302033
Source DB: PubMed Journal: Mo Med ISSN: 0026-6620